Current Opinion in Nephrology and Hypertension

Article	Citations
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	28
Editorial introductions	27
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	27
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	26
Maximizing opportunities for kidney transplantation in older adults	24
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	21
Dual organ transplantation: Pancreas and Liver in the kidney axis	20
The clinical application of frailty in nephrology and transplantation	19
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	19
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	18
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	18
Interferon gamma in the pathogenesis of hypertension − recent insights	18
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	17
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	17
Prediction models for earlier stages of chronic kidney disease	15
International equity in access to home dialysis	15
Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population	14
Modern indications for referral for kidney and pancreas transplantation	14
Editorial introduction	14
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	14
Bringing the end-stage kidney disease life plan home	13
Renal denervation for the treatment of hypertension and kidney disease	13
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	13
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	12
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	12

Staying home when peritoneal dialysis ends: the integrated home dialysis approach	12
Plant-based diets for kidney disease prevention and treatment	11
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	11
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	10
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	10
Built environment and chronic kidney disease: current state and future directions	10
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	10
The race coefficient in glomerular filtration rate-estimating equations and its removal	10
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	10
Editorial: One size does not fit all: moving toward individualized therapy	9
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	9
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	9
Complement detection in kidney biopsies – utility and challenges	9
Combination therapy with kidney protective therapies: optimizing the benefits?	9
Understanding renal phosphate handling: unfinished business	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	8
Lipocalin-2: a novel link between the injured kidney and the bone	8
Climate change and kidney stones	8
Advances in management of hepatorenal syndrome	8
Editorial introductions	8
Cancer drugs and acute kidney injury: new therapies and new challenges	8
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one	8
Noninvasive continuous intradialytic blood pressure monitoring: the key to improving haemodynamic stability	8
Editorial: Advancements in the management of kidney disease and electrolyte derangements	8
Impact of intensive blood pressure control on kidney outcomes	7
Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice	7
Recent advances in dialysis membranes	7
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	7
Automation and innovation in home hemodialysis machines	7
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	7
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	7
New insights into renal calcium-sensing receptor activation	7
Deep learning applications for kidney histology analysis	7
The current therapeutic approach for anaemia after kidney transplant	7
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	7
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	7
HIV-associated kidney disease: the changing spectrum and treatment priorities	7
Renal osteodystrophy: something old, something new, something needed	6
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Renal denervation: recent developments in clinical and preclinical research	6
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	6
Sex differences in renal electrolyte transport	6
Editorial introduction	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Prospects for gene therapy in polycystic kidney disease	6
Hypernatremia in the intensive care unit	6
New and old approaches to nutritional management of acute and chronic glomerulonephritis	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Contemporary risk prediction models in chronic kidney disease: when less is more	6

Editorial introductions	6
Evolving thresholds for the diagnosis of acute T cell mediated rejection	6
Novel intestinal dialysis interventions and microbiome modulation to control uremia	5
The genetics of cystinuria – an update and critical reevaluation	5
Building kidney organoids from pluripotent stem cells	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	5
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis	5
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	5
The changing trajectory of diabetic kidney disease	5
Editorial: A humble way forward amid hype and hope	5
Evolving indications and management patterns in heart – kidney transplantation	5
Screening for chronic kidney disease: change of perspective and novel developments	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
Editorial introductions	5
Novel approaches in antihypertensive pharmacotherapeutics	5
Targeting inflammation in hypertension	4
Chronic kidney disease and sex dimorphism	4
Novel agents for treating IgA nephropathy	4
Fibroblast growth factor 23 as a risk factor for incident diabetes	4
Electrolytes disturbances in cancer patients	4
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	4
Cystatin C should be routinely available for estimating kidney function	4
An update on corticosteroid treatment for IgA nephropathy	4
New therapeutics for primary hyperoxaluria type 1	4
The potential of artificial intelligence-based applications in kidney pathology	4
Editorial introductions	4
Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension	4
The role of calprotectin in vascular calcification	4
The « race » correction in estimating glomerular filtration rate: an European point of view	4
Population health strategies for health equity in chronic kidney disease management	4
Effects of aging on chronic kidney disease mineral and bone disorder	4
COVID-19 in patients with glomerular disease	4
WNK1 in the kidney	4
Fifty years of basic and clinical renal stone research: have we achieved major breakthroughs? A debate	4
Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease–mineral and bone disorder	3
The role of osteopontin in chronic kidney disease-mineral bone disorder	3
Editorial introductions	3
Mendelian randomization and the association of fibroblast growth factor-23 with heart failure with preserved ejection fraction	3
Updated diagnostic and therapeutic management for membranous nephropathy	3
Postnatal renal tubule development: roles of tubular flow and flux	3
Fibroblast growth factor 23, klotho and heparin	3
Editorial introductions	3
Factors that lead to dialysis as the preferred treatment modality for patients with chronic kidney disease	3
Agents to treat osteoporosis in chronic kidney disease	3
Editorial introductions	3
Glomerular filtration rate and sexual dimorphism: lessons from animal and human studies	3
Editorial introduction	3
The promise of artificial intelligence for kidney pathophysiology	3
Home dialysis: there's no place like home	3
Indications for and results of renal autotransplantation	3
Editorial introductions	3
Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach	3
Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation	3
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide	3
Progress in the management of patients with diabetes and chronic kidney disease	3
Phosphate sensing in health and disease	3
Insights into proliferative glomerulonephritis with monoclonal immunoglobulin deposits – is it really monoclonal or not?	3
Efficacy and safety of Sodium-Glucose-Transporter-2 inhibitors in kidney transplant patients	3
Climate crisis and nephrology: a review of climate change's impact on nephrology and how to combat it	3
Climate change and its influence in nephron mass	3
Use of water in dialysis and its impact on the environment	3
Pruritus in chronic kidney disease	3
The times they are K+-changin’: bringing the potassium curriculum out of the 20th century	3
Literature review: are NSAIDs harmful and is acetaminophen well tolerated?	3
Social and humanitarian issues in nephrology and hypertension	2
Challenges in standardizing preimplantation kidney biopsy assessments and the potential of AI-Driven solutions	2
Skin autofluorescence as tool for cardiovascular and diabetes risk prediction	2
Updates on renal phosphate transport	2
Implications of climate change on acute kidney injury	2
Let's stop talking about ‘citrate toxicity’	2
Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection	2
Uromodulin: more than a marker for chronic kidney disease progression	2
Targeting aldosterone to improve cardiorenal outcomes: from nonsteroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors	2
APOL1 nephropathy – a population genetics success story	2
Recent advances in the understanding of the peritoneal membrane	2
Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy	2

How to assess quality of life in persons with chronic kidney disease	2
Justifying access to kidney care in low resource and humanitarian settings	2
Editorial introductions	2
Communication principles and practices for making shared decisions about renal replacement therapy: a review of the literature	2
Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury	2
Kidney health and function with left ventricular assist devices	2
Heating up: climate change and the threat to human health	2
Chronic kidney disease with unknown cause across the global spectrum	2
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship	2
Lysine and salt-sensitive hypertension	2
Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder	2
Novel pharmacological interventions for diabetic kidney disease	2
Community acquired and hospital acquired AKI - two diseases divided by a common definition	2
Cellular and molecular interrogation of kidney biopsy specimens	2
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker	2
Centering marginalized voices in advocacy for equitable policy change in kidney disease	2
Applications of cardiac biomarkers in chronic kidney disease	2
KCa3.1 in diabetic kidney disease	2
Contribution of phosphate and FGF23 to CKD progression	2
Do not forget about transplant patients during disasters	2
Editorial introductions	2